138 related articles for article (PubMed ID: 10933368)
1. Estrogen is associated with improved survival in aging women with congestive heart failure: analysis of the vesnarinone studies.
Reis SE; Holubkov R; Young JB; White BG; Cohn JN; Feldman AM
J Am Coll Cardiol; 2000 Aug; 36(2):529-33. PubMed ID: 10933368
[TBL] [Abstract][Full Text] [Related]
2. Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group.
Feldman AM; Bristow MR; Parmley WW; Carson PE; Pepine CJ; Gilbert EM; Strobeck JE; Hendrix GH; Powers ER; Bain RP
N Engl J Med; 1993 Jul; 329(3):149-55. PubMed ID: 8515787
[TBL] [Abstract][Full Text] [Related]
3. A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. Vesnarinone Trial Investigators.
Cohn JN; Goldstein SO; Greenberg BH; Lorell BH; Bourge RC; Jaski BE; Gottlieb SO; McGrew F; DeMets DL; White BG
N Engl J Med; 1998 Dec; 339(25):1810-6. PubMed ID: 9854116
[TBL] [Abstract][Full Text] [Related]
4. Effect of vesnarinone on cardiac function in patients with severe congestive heart failure.
Scherrer-Crosbie M; Cocca-Spofford D; DiSalvo TG; Semigran MJ; Dec GW; Picard MH
Am Heart J; 1998 Nov; 136(5):769-77. PubMed ID: 9812070
[TBL] [Abstract][Full Text] [Related]
5. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
6. Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial.
Oliva F; Latini R; Politi A; Staszewsky L; Maggioni AP; Nicolis E; Mauri F
Am Heart J; 1999 Aug; 138(2 Pt 1):247-53. PubMed ID: 10426835
[TBL] [Abstract][Full Text] [Related]
7. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).
Deswal A; Petersen NJ; Feldman AM; Young JB; White BG; Mann DL
Circulation; 2001 Apr; 103(16):2055-9. PubMed ID: 11319194
[TBL] [Abstract][Full Text] [Related]
8. Vesnarinone: a new inotropic agent for treating congestive heart failure.
Cavusoglu E; Frishman WH; Klapholz M
J Card Fail; 1995 Jun; 1(3):249-57. PubMed ID: 9420657
[TBL] [Abstract][Full Text] [Related]
9. Incidence, predictive factors, and prognostic significance of supraventricular tachyarrhythmias in congestive heart failure.
Mathew J; Hunsberger S; Fleg J; Mc Sherry F; Williford W; Yusuf S
Chest; 2000 Oct; 118(4):914-22. PubMed ID: 11035656
[TBL] [Abstract][Full Text] [Related]
10. Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure.
Senior R; Kaul S; Lahiri A
J Am Coll Cardiol; 1999 Jun; 33(7):1848-54. PubMed ID: 10362184
[TBL] [Abstract][Full Text] [Related]
11. Effect of inotrope withdrawal on morbidity and mortality in patients with chronic heart failure: results of the vesnarinone trial withdrawal substudy. Vest Withdrawal Substudy Group.
Soran O; Young JD; Holubkov R; Loftus S; Bourge R; Carson P; Jaski B; White BG; Feldman AM
J Card Fail; 1999 Sep; 5(3):195-200; discussion 201-2. PubMed ID: 10496192
[TBL] [Abstract][Full Text] [Related]
12. Hormone replacement therapy is associated with improved survival in women with advanced heart failure.
Lindenfeld J; Ghali JK; Krause-Steinrauf HJ; Khan S; Adams K; Goldman S; Peberdy MA; Yancy C; Thaneemit-Chen S; Larsen RL; Young J; Lowes B; Rosenberg YD;
J Am Coll Cardiol; 2003 Oct; 42(7):1238-45. PubMed ID: 14522488
[TBL] [Abstract][Full Text] [Related]
13. Association of beta-blocker use with mortality among patients with congestive heart failure in the Cardiovascular Health Study (CHS).
Chan JD; Rea TD; Smith NL; Siscovick D; Heckbert SR; Lumley T; Chaves P; Furberg CD; Kuller L; Psaty BM
Am Heart J; 2005 Sep; 150(3):464-70. PubMed ID: 16169325
[TBL] [Abstract][Full Text] [Related]
14. Risk stratification for coronary bypass surgery in patients with left ventricular dysfunction: analysis of the coronary artery bypass grafting patch trial database.
Argenziano M; Spotnitz HM; Whang W; Bigger JT; Parides M; Rose EA
Circulation; 1999 Nov; 100(19 Suppl):II119-24. PubMed ID: 10567289
[TBL] [Abstract][Full Text] [Related]
15. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. PROMISE (Prospective Randomized Milrinone Survival Evaluation) Investigators.
Teerlink JR; Jalaluddin M; Anderson S; Kukin ML; Eichhorn EJ; Francis G; Packer M; Massie BM
Circulation; 2000 Jan 4-11; 101(1):40-6. PubMed ID: 10618302
[TBL] [Abstract][Full Text] [Related]
16. Contemporary medical management of left ventricular dysfunction and congestive heart failure.
Teo KK; Ignaszewski AP; Gutierrez R; Hill KL; Martin SL; Calhoun HP; Humen DP; Montague TJ
Can J Cardiol; 1992; 8(6):611-9. PubMed ID: 1354569
[TBL] [Abstract][Full Text] [Related]
17. Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials.
Young JB; Dunlap ME; Pfeffer MA; Probstfield JL; Cohen-Solal A; Dietz R; Granger CB; Hradec J; Kuch J; McKelvie RS; McMurray JJ; Michelson EL; Olofsson B; Ostergren J; Held P; Solomon SD; Yusuf S; Swedberg K;
Circulation; 2004 Oct; 110(17):2618-26. PubMed ID: 15492298
[TBL] [Abstract][Full Text] [Related]
18. Insights into the contemporary epidemiology and outpatient management of congestive heart failure.
McAlister FA; Teo KK; Taher M; Montague TJ; Humen D; Cheung L; Kiaii M; Yim R; Armstrong PW
Am Heart J; 1999 Jul; 138(1 Pt 1):87-94. PubMed ID: 10385769
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic therapy is associated with better survival in patients with severe heart failure and left ventricular systolic dysfunction (EPICAL study).
Echemann M; Alla F; Briançon S; Juillière Y; Virion JM; Mertès PM; Villemot JP; Zannad F; Aliot E; Breton Ch; KhalifE K; Neimann JL; Allam S; Admant P; Baille N; Bellanger P; D'Hôtel R; Dambrine P; Dodet JF; Graille M; Kessler M; Rebeix G; Royer ; Saulnier JP; Thisse JY; Trutt B; Vidal P; Vuillemin MCh; Delahaye ; Ducimetière P; Fagnani F; Guize L;
Eur J Heart Fail; 2002 Oct; 4(5):647-54. PubMed ID: 12413509
[TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy and the risk of incident congestive heart failure: the Cardiovascular Health Study.
Rea TD; Psaty BM; Heckbert SR; Cushman M; Meilahn E; Olson JL; Lemaitre RN; Smith NL; Sotoodehnia N; Chaves PH
J Womens Health (Larchmt); 2003 May; 12(4):341-50. PubMed ID: 12804341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
